Literature DB >> 10768299

Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons.

R J DeLorenzo1, S Sombati, D A Coulter.   

Abstract

PURPOSE: In this study, we examined the effects of topiramate (TPM) on the electrophysiologic properties of cultured rat hippocampal pyramidal neurons.
METHODS: Whole-cell current-clamp recording techniques were used to determine the effects of TPM on sustained repetitive firing (SRF), spontaneous epileptiform-burst firing, and spontaneous recurrent seizures (SRS).
RESULTS: Topiramate at therapeutic concentrations (10-100 microM) significantly decreased or abolished SRF in a dose-dependent and partially reversible manner. When transiently exposed to a medium in which Mg2+ is omitted, hippocampal neurons in culture develop SRS ("epilepsy") and epileptiform discharges. Application of TPM at concentrations ranging from 10 to 100 microM to cells displaying seizure activity caused a concentration-dependent decrease in the number of action potentials within a burst and in the average duration of epileptiform activity. Both effects were partially reversed during a 5- to 30-min drug washout period.
CONCLUSIONS: These effects on the electrophysiologic properties of cultured neurons are consistent with the concept that TPM exerts modulatory effects on voltage-dependent Na+ and/or Ca2+ conductances responsible for the generation and propagation of action potentials. Topiramate also may inhibit synaptic conductances responsible for transmission of epileptiform discharges.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768299     DOI: 10.1111/j.1528-1157.2000.tb06048.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  42 in total

1.  Antiepileptic drugs and cortical excitability: a study with repetitive transcranial stimulation.

Authors:  M Inghilleri; A Conte; V Frasca; A Curra'; F Gilio; M Manfredi; A Berardelli
Journal:  Exp Brain Res       Date:  2003-10-25       Impact factor: 1.972

2.  Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Maria Sudell; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-06-24

Review 3.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

4.  Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism.

Authors:  Sandra Ghelardoni; Richard P Bazinet; Stanley I Rapoport; Francesca Bosetti
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

5.  Phosphorylation of sodium channels mediated by protein kinase-C modulates inhibition by topiramate of tetrodotoxin-sensitive transient sodium current.

Authors:  G Curia; P Aracri; E Colombo; P Scalmani; M Mantegazza; G Avanzini; S Franceschetti
Journal:  Br J Pharmacol       Date:  2007-02-05       Impact factor: 8.739

Review 6.  Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

Authors:  Sarah J Nevitt; Maria Sudell; Jennifer Weston; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2017-06-29

Review 7.  Topiramate add-on therapy for drug-resistant focal epilepsy.

Authors:  Rebecca Bresnahan; Juliet Hounsome; Nathalie Jette; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-10-23

8.  Enteral topiramate in a pediatric patient with refractory status epilepticus: a case report and review of the literature.

Authors:  Chasity M Shelton; Elizabeth L Alford; Stephanie Storgion; James Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

9.  Antiischemic effects of topiramate in a transient global forebrain ischemia model: a neurochemical, histological, and behavioral evaluation.

Authors:  S H Khan; Sandra Lea Wright; Ali Banigesh; Hiro Miyashita; Kathryn Todd; Susan Jean Hemmings; Tom Wishart; Ashfaq Shuaib
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

10.  Topiramate in the treatment of partial and generalized epilepsy.

Authors:  Edward Faught
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.